Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

The NIPAL4 mutation c.527C>A is common in Romanian patients with autosomal recessive congenital ichthyosis.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

COVID-19 vaccination may trigger lupus in some people.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Suppressing ODC activity reduces tumor growth in hair follicles.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

A specific gene change in APCDD1 increases the risk of hair loss.

Activated erbB-2 in mice skin causes severe skin and hair abnormalities.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Mice with alopecia areata had wider lymphatic vessels in their skin.

Cyclosporin A significantly increases hair growth in certain areas of mice.

The 736T>A mutation in the LIPH gene is common in Japanese people with autosomal recessive woolly hair.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Alopecia areata may be linked to kidney issues, but more research is needed.

4-aminopyridine, a FDA-approved drug, speeds up skin wound healing and tissue regeneration.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

4-aminopyridine helps skin wounds heal faster and better.

Genetic differences affect COVID-19 severity and treatment development.

Virus infection risk is linked to heat tolerance and size, but decreases with high humidity and mutation rates.

Mast cells and the CB1 receptor may be key in causing IgA vasculitis.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

MicroRNA-181a slows sheep hair growth by targeting GNAI2 and affecting a key growth pathway.

NCSTN gene mutation causes abnormal skin cell differentiation and more inflammation, contributing to Hidradenitis Suppurativa.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.